PHVS
Pharvaris NV
-30.10%
$9.60 - $6.71
Feb 7th 2023 - Mar 21st 2023
Dec, 9, 2022
$PHVS was absolutly amazing💸💸💸 don’t forget on $ARDX FDA approval news coming out on the 16th… could make similar move…
No reviews available.
Mar, 13, 2023
gets a drug approved and immediately rewards shareholders!!!
Feb, 22, 2023
$PRVB 8.60 to 8.80 has been good support since approval.
Feb, 18, 2023
If that gets approved its 10.000 times better than Provention Bio.
Feb, 6, 2023
Great to see the FDA approval, as well as $SNY commitment.
Nov, 25, 2022
$PRVB While reaching this milestone of approval has been inspirational, it is now the aspirational goal of population screening which is at the forefront.
Nov, 22, 2022
It works, there is a need for it, there is insurance buy in on it, there is a global sales team, there is further label expansion and approvals in the future, and there are additional drugs in the pipeline from this company that show the same promise.
Nov, 21, 2022
PRVB is in a MUCH better financial situation now with FDA approval giving them a multi-billion USD asset (Teplizumab) which they can get conventional financing from A BANK!!
Nov, 21, 2022
It's APPROVED !!
Nov, 18, 2022
$PRVB Interesting they received approval which is good.
Nov, 18, 2022
$PRVB good that they have got an approval.